Knoll Capital Management as of Sept. 30, 2013
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 11 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 79.5 | $149M | 2.5M | 59.94 | |
| Ampio Pharmaceuticals | 8.1 | $15M | 2.0M | 7.50 | |
| Alcobra | 5.7 | $11M | 587k | 18.04 | |
| Vivus | 2.5 | $4.7M | 500k | 9.30 | |
| Genworth Financial (GNW) | 1.4 | $2.7M | 211k | 12.80 | |
| Sequenom | 1.3 | $2.4M | 894k | 2.67 | |
| Newlink Genetics Corporation | 0.8 | $1.5M | 77k | 18.78 | |
| Keryx Biopharmaceuticals | 0.5 | $1.0M | 100k | 10.09 | |
| Celgene Corporation | 0.1 | $225k | 28k | 8.06 | |
| EXACT Sciences Corporation (EXAS) | 0.1 | $165k | 14k | 11.79 | |
| Echo Therapeutics | 0.1 | $123k | 44k | 2.77 |
